Bob is a graduate of Columbia Business School. He has been a Sr Analyst at Lehman as well as Bear Stearns, where he focused on Internet and technology. Bob then led Internet research at Baron Capital and has been quoted on CNBC and the WSJ.
Biotech swing trader. My 1st five Questions:
1) How much money do they have?
2) Date of last offering?
3) What & when is the next catalyst?
4) What's their cash burn?
5) Do they have a credit facility?